Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

What are Biosimilar Drugs?

Share Post:

What are biosimilar drugs?

In its simplest definition, biosimilar drugs are synthetic versions of biologic drugs that have been utilized to treat various illnesses and conditions. These are medicines that are very close to biologic drugs in terms of their function and structure.

In order to understand biosimilars, it is essential to know about biologics first. Biologics consists of proteins made by living organisms. It is entirely different from traditional drugs, where chemicals are used and are referred to as small molecules contained in pills like aspirin.

As mentioned, biosimilars act as a replica of biologic drugs. Each of the produced biosimilars is made with the same materials and similar processes as its reference medicines. These reference medicines are biologic drugs that have been used for many years now. The best examples of biologic drugs are Infliximab (Remicade), Etanercept (Enbrel), and Adalimumab (Humira).

Biosimilars vs Generics

The main differences between biosimilars and generics involve their molecular sizes, structures, complexity, and costs of their development. Consider the following information:

Biosimilar drugs, alongside their reference biologic medicines, are very much the same but not entirely identical. This is because of the following reasons:

  • Biologic drugs are large and complex.
  • Biologic drugs consist of living organisms instead of chemicals.

On the other hand, generic drugs have identical properties to their reference medicines. Unlike biosimilars, generics are made of small molecules that are produced with chemical ingredients and processes. Generic drugs are the exact copies of what we call branded medications.

FDA-approved biosimilars

The following are biosimilar drugs approved by the Food and Drug Administration. The table below includes their reference products and approval date.

  Biosimilar Drugs  Reference Products (Medicines)  Approval Dates
Byooviz (ranibizumab-nuna)Lucentis (ranibizumab)September 2021 
Rezvoglar (insulin glargine-aglr)Lantus (insulin glargine)December 2021
Yusimry (adalimumab-aqvh)Humira (adalimumab)December 2021
Releuko (filgrastim-ayow)Neupogen (filgrastim)February 2022
Alymsys (bevacizumab-maly)Avastin (bevacizumab)April 2022
Fylnetra (pegfilgrastim-pbbk)Neulasta (pegfilgrastim)May 2022
Cimerli (ranibizumab-eqrn)Lucentis (ranibizumab) August 2022
Stimufend (pegfilgrastim-fpgk)Neulasta (pegfilgrastim)September 2022
Vegzelma (bevacizumab-adcd)Avastin (bevacizumab)September 2022
Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on November 21, 2022

Related Articles

Cardiovascular Health, Diabetes,
How SGLT2 Inhibitors Are Changing Heart Failure Care

Heart failure is a long-term health condition impacting millions worldwide. It occurs when the heart can’t pump blood efficiently, resulting in symptoms like fatigue, breathlessness, and swelling. Traditionally, treatment has…

Read More
Diabetes, Diabetes Supplies,
Basaglar Cartridge: Long-Acting Insulin for Diabetes

Managing diabetes requires consistent attention, especially when it comes to regulating blood sugar levels. Among the tools used in long-term diabetes care is long-acting insulin, and one notable option is…

Read More
Diabetes, Diabetes Supplies,
Xultophy® Prefilled Pen: Insulin + GLP-1 for Diabetes Care

Managing type 2 diabetes is often a balancing act that involves careful monitoring, lifestyle adjustments, and effective medication. For many patients, finding a treatment that delivers strong blood sugar control…

Read More
Diabetes, Diabetes Supplies,
GLP-1 Drugs Drive Surge in Weight Loss Prescriptions

The treatment landscape for obesity is evolving rapidly. While lifestyle modifications and surgery have long been the primary options, a new class of medications called GLP-1 drugs has emerged as…

Read More